US 10059668
LSD1 inhibitors
granted A61PA61P35/00
Quick answer
US patent 10059668 (LSD1 inhibitors) held by Mirati Therapeutics, Inc. expires Mon Aug 23 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Mirati Therapeutics, Inc.
- Grant date
- Tue Aug 28 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 23 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 22
- CPC classes
- A61P, A61P35/00